logo
  

Torotrak Appoints Nick Barter To Replace John Weston As Chairman; Stock Up

Torotrak plc's (TRK.L) shares increased around 4 percent in the morning trading in London after the provider of gearless traction drive technology to reduce carbon-dioxide emissions in vehicles said Wednesday that it has appointed Nick Barter, currently the senior independent director, to replace Chairman John Weston.

The company noted that Westo, who has has stepped down as Chairman after nearly four years, will remain on the board as the senior non-executive director.

Barter said, "Having led the Board since 2011, including through the successful acquisition of Flybrid, John has made a major contribution to Torotrak."

Weston added, "With Flybrid being part of Torotrak's offering, market opportunities are opening up as we had hoped and I believe that at this stage someone with Nick's automotive experience is crucial for taking full advantage of this next phase of the Company's development."

The company noted that its business is in a stronger position than 12 months ago, with real progress towards revenue generation on a number of new opportunities.

The company will provide a more detailed update at the time of the interim results that are due to be released on November 27.

In London, Torotrak shares were gaining 0.64 pence or 4.49 percent, and trading at 14.89 pence.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Dr. Reddy's Laboratories Ltd. is recalling six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer level. According to the U.S. Food and Drug Administration, the recall was due to powder discoloration in some packets leading to decreased potency. Philip Morris International Inc. (PM) reported Tuesday that net earnings attributable to PMI for the quarter grew to $2.15 billion or $1.38 per share from $2.00 billion or $1.28 per share in the prior-year quarter. Excluded items, adjusted earnings for the quarter were $1.50 per share, compared to... Novartis AG's shares were gaining more than 4 percent in Switzerland and more than 5 percent in pre-market activity on the NYSE after the Swiss drug major reported Tuesday higher first-quarter profit, above market estimates, with strong sales growth. The company also raised its fiscal 2024 outlook for growth in sales and core operating income.

First quarter growth data from China gained the maximum focus this week as trends in the massive emerging economy impact its trading partners. Elsewhere, the IMF released its latest global macroeconomic projections. Read our story to find out why comments from the Fed Chair Powell damped rate cut expectations. Meanwhile, there was some survey data that kindled hopes of a recovery in manufacturing. In the U.K., inflation data for March revealed some confusing trends.

View More Videos
Follow RTT